MicroRNA Expression Profiles of Whole Blood in Lung Adenocarcinoma

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Patnaik, Santosh K ^a   Yendamuri, Sai ^a   Kannisto, Eric ^a   Kucharczuk, John C ^b   Singhal, Sunil ^b   Vachani, Anil ^c  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; MICRORNA; MICRORNA 1284; MICRORNA 190B; MICRORNA 630; MICRORNA 942; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER RISK; CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; KERNEL METHOD; LEUKOCYTE COUNT; LUNG ADENOCARCINOMA; MALE; NUCLEOTIDE SEQUENCE; PREDICTIVE VALUE; RACE DIFFERENCE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING; SUPPORT VECTOR MACHINE; THROMBOCYTE COUNT; TOP SCORING PAIR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866980740     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046045     Document Type: Article

References (71)

1. Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, et al. (2011) Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 103: 714-736.
2. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365: 395-409.
3. Ost D, Fein A, (2000) Evaluation and management of the solitary pulmonary nodule. American journal of respiratory and critical care medicine 162: 782-787.
4. Ost DE, Gould MK, (2012) Decision making in patients with pulmonary nodules. American journal of respiratory and critical care medicine 185: 363-372.
5. MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, et al. (2005) Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 237: 395-400.
6. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell research 18: 997-1006.
7. Bianchi F, Nicassio F, Marzi M, Belloni E, Dall'olio V, et al. (2011) A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO molecular medicine 3: 495-503.
8. Hennessey PT, Sanford T, Choudhary A, Mydlarz WW, Brown D, et al. (2012) Serum microRNA biomarkers for detection of non-small cell lung cancer. PLoS One 7: e32307.
9. Boeri M, Verri C, Conte D, Roz L, Modena P, et al. (2011) MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proceedings of the National Academy of Sciences of the United States of America 108: 3713-3718.
10. Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, et al. (2011) Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Laboratory investigation; a journal of technical methods and pathology 91: 579-587.
11. Zheng D, Haddadin S, Wang Y, Gu LQ, Perry MC, et al. (2011) Plasma microRNAs as novel biomarkers for early detection of lung cancer. International journal of clinical and experimental pathology 4: 575-586.
12. Heegaard NH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, et al. (2012) Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. International journal of cancer Journal international du cancer 130: 1378-1386.
13. Patnaik SK, Mallick R, Yendamuri S, (2010) Detection of microRNAs in dried serum blots. Analytical biochemistry 407: 147-149.
14. Rykova EY, Wunsche W, Brizgunova OE, Skvortsova TE, Tamkovich SN, et al. (2006) Concentrations of circulating RNA from healthy donors and cancer patients estimated by different methods. Annals of the New York Academy of Sciences 1075: 328-333.
15. Garcia JM, Garcia V, Pena C, Dominguez G, Silva J, et al. (2008) Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched. Rna 14: 1424-1432.
16. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A, (2010) Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57: 833-840.
17. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, et al. (2012) Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 5: 492-497.
18. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
19. Brase JC, Johannes M, Schlomm T, Falth M, Haese A, et al. (2011) Circulating miRNAs are correlated with tumor progression in prostate cancer. International journal of cancer Journal international du cancer 128: 608-616.
20. Wulfken LM, Moritz R, Ohlmann C, Holdenrieder S, Jung V, et al. (2011) MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. PLoS One 6: e25787.
21. Chen X, Liang H, Zhang J, Zen K, Zhang CY, (2012) Secreted microRNAs: a new form of intercellular communication. Trends in cell biology 22: 125-132.
22. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences of the United States of America 103: 2257-2261.
23. Roth P, Wischhusen J, Happold C, Chandran PA, Hofer S, et al. (2011) A specific miRNA signature in the peripheral blood of glioblastoma patients. Journal of neurochemistry 118: 449-457.
24. Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, et al. (2012) Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One 7: e29770.
25. Hausler SF, Keller A, Chandran PA, Ziegler K, Zipp K, et al. (2010) Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer 103: 693-700.
26. Bauer AS, Keller A, Costello E, Greenhalf W, Bier M, et al. (2012) Diagnosis of Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis by Measurement of microRNA Abundance in Blood and Tissue. PLoS One 7: e34151.
27. Keller A, Leidinger P, Bauer A, Elsharawy A, Haas J, et al. (2011) Toward the blood-borne miRNome of human diseases. Nat Methods 8: 841-843.
28. Meder B, Keller A, Vogel B, Haas J, Sedaghat-Hamedani F, et al. (2011) MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic research in cardiology 106: 13-23.
29. Maertzdorf J, Weiner J 3rd, Mollenkopf HJ, Bauer T, Prasse A,et al. (2012) Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proceedings of the National Academy of Sciences of the United States of America.
30. Zander T, Hofmann A, Staratschek-Jox A, Classen S, Debey-Pascher S, et al. (2011) Blood-based gene expression signatures in non-small cell lung cancer. Clin Cancer Res 17: 3360-3367.
31. Keller A, Leidinger P, Borries A, Wendschlag A, Wucherpfennig F, et al. (2009) miRNAs in lung cancer- studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 9: 353.
32. Keller A, Backes C, Leidinger P, Kefer N, Boisguerin V, et al. (2011) Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients. Molecular bioSystems 7: 3187-3199.
33. Jeong HC, Kim EK, Lee JH, Lee JM, Yoo HN, et al. (2011) Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients. Molecular medicine reports 4: 383-387.
34. Leidinger P, Keller A, Borries A, Huwer H, Rohling M, et al. (2011) Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung cancer 74: 41-47.
35. Castoldi M, Schmidt S, Benes V, Noerholm M, Kulozik AE, et al. (2006) A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). Rna 12: 913-920.
36. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
37. Smyth G (2005) Limma: linear models for microarray data. In: Gentleman R, Carey VJ, Huber W, Dudoit S, Irizarry RA, editors. Bioinformatics and Computational Biology Solutions using R and Bioconductor. New York: Springer. 397-420.
38. Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, et al. (2007) A comparison of background correction methods for two-colour microarrays. Bioinformatics 23: 2700-2707.
39. Berger JA, Hautaniemi S, Jarvinen AK, Edgren H, Mitra SK, et al. (2004) Optimized LOWESS normalization parameter selection for DNA microarray data. BMC Bioinformatics 5: 194.
40. Slawski M, Daumer M, Boulesteix AL, (2008) CMA: a comprehensive Bioconductor package for supervised classification with high dimensional data. BMC Bioinformatics 9: 439.
41. Leek JT, (2009) The tspair package for finding top scoring pair classifiers in R. Bioinformatics. 25: 1203-1204.
42. Xu L, Tan AC, Naiman DQ, Geman D, Winslow RL, (2005) Robust prostate cancer marker genes emerge from direct integration of inter-study microarray data. Bioinformatics 21: 3905-3911.
43. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, et al. (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179.
44. Vergara IA, Norambuena T, Ferrada E, Slater AW, Melo F, (2008) StAR: a simple tool for the statistical comparison of ROC curves. BMC Bioinformatics 9: 265.
45. Saeed AI, Sharov V, White J, Li J, Liang W, et al. (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34: 374-378.
46. Muller MC, Merx K, Weisser A, Kreil S, Lahaye T, et al. (2002) Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization. Leukemia 16: 2395-2399.
47. Kagedal B, Lindqvist M, Farneback M, Lenner L, Peterson C, (2005) Failure of the PAXgene Blood RNA System to maintain mRNA stability in whole blood. Clin Chem Lab Med 43: 1190-1192.
48. Chai V, Vassilakos A, Lee Y, Wright JA, Young AH, (2005) Optimization of the PAXgene blood RNA extraction system for gene expression analysis of clinical samples. J Clin Lab Anal 19: 182-188.
49. Hammerle-Fickinger A, Riedmaier I, Becker C, Meyer HH, Pfaffl MW, et al. (2010) Validation of extraction methods for total RNA and miRNA from bovine blood prior to quantitative gene expression analyses. Biotechnol Lett 32: 35-44.
50. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ, (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-144.
51. Wang B, Howel P, Bruheim S, Ju J, Owen LB, et al. (2011) Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array. PLoS One 6: e17167.
52. Dudoit S, Fridyland J (2003) Classification in microarray experiments. In: Speed T, editor. Statistical Analysis of Gene Expression Microarray Data. 1 ed: Chapman and Hall/CRC. 93-158.
53. DeLong ER, DeLong DM, Clarke-Pearson DL, (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
54. Hamilton AJ, (2010) MicroRNA in erythrocytes. Biochem Soc Trans 38: 229-231.
55. Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, et al. (2011) Haemolysis during sample preparation alters microRNA content of plasma. PLoS One 6: e24145.
56. Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, et al. (2011) Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. Journal of molecular and cellular cardiology 51: 872-875.
57. Pirker R, Wiesenberger K, Pohl G, Minar W, (2003) Anemia in lung cancer: clinical impact and management. Clin Lung Cancer 5: 90-97.
58. Shoenfeld Y, Tal A, Berliner S, Pinkhas J, (1986) Leukocytosis in non hematological malignancies-a possible tumor-associated marker. J Cancer Res Clin Oncol 111: 54-58.
59. Tomita M, Shimizu T, Ayabe T, Yonei A, Onitsuka T, (2010) Prognostic significance of tumour marker index based on preoperative CEA and CYFRA 21-1 in non-small cell lung cancer. Anticancer Res 30: 3099-3102.
60. Guan P, Yin Z, Li X, Wu W, Zhou B, (2012) Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. Journal of experimental & clinical cancer research: CR 31: 54.
61. Hu Z, Chen X, Zhao Y, Tian T, Jin G, et al. (2010) Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 28: 1721-1726.
62. Foss KM, Sima C, Ugolini D, Neri M, Allen KE, et al. (2011) miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 6: 482-488.
63. Morandi E, Severini C, Quercioli D, Perdichizzi S, Mascolo MG, et al. (2009) Gene expression changes in medical workers exposed to radiation. Radiat Res 172: 500-508.
64. Fachin AL, Mello SS, Sandrin-Garcia P, Junta CM, Ghilardi-Netto T, et al. (2009) Gene expression profiles in radiation workers occupationally exposed to ionizing radiation. J Radiat Res (Tokyo) 50: 61-71.
65. Cui W, Ma J, Wang Y, Biswal S, (2011) Plasma miRNA as biomarkers for assessment of total-body radiation exposure dosimetry. PLoS One 6: e22988.
66. Orlova IA, Alexander GM, Qureshi RA, Sacan A, Graziano A, et al. (2011) MicroRNA modulation in complex regional pain syndrome. Journal of translational medicine 9: 195.
67. Weber M, Baker MB, Patel RS, Quyyumi AA, Bao G, et al. (2011) MicroRNA Expression Profile in CAD Patients and the Impact of ACEI/ARB. Cardiology research and practice 2011: 532915.
68. Fukushima Y, Nakanishi M, Nonogi H, Goto Y, Iwai N, (2011) Assessment of plasma miRNAs in congestive heart failure. Circulation journal: official journal of the Japanese Circulation Society 75: 336-340.
69. Shende VR, Goldrick MM, Ramani S, Earnest DJ, (2011) Expression and rhythmic modulation of circulating microRNAs targeting the clock gene Bmal1 in mice. PLoS One 6: e22586.
70. Katsuura S, Kuwano Y, Yamagishi N, Kurokawa K, Kajita K, et al. (2012) MicroRNAs miR-144/144* and miR-16 in peripheral blood are potential biomarkers for naturalistic stress in healthy Japanese medical students. Neuroscience letters 516: 79-84.
71. Radom-Aizik S, Zaldivar F Jr, Oliver S, Galassetti P, Cooper DM, (2010) Evidence for microRNA involvement in exercise-associated neutrophil gene expression changes. Journal of applied physiology 109: 252-261.